| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 10% | $12,292,327 | 17,560,467 | Vivo Opportunity Fund Holdings, L.P. | 01 Dec 2025 | |||
| JANUS HENDERSON GROUP PLC | 10% | $10,843,431 | 10,229,652 | JANUS HENDERSON GROUP PLC | 28 Nov 2025 | |||
| Squadron Capital Management LLC | 9.9% | $1,577,051 | 2,252,930 | Squadron Capital Management LLC | 28 Nov 2025 | |||
| CVI Investments, Inc. | 9.9% | 0% | $702,223 | +$169,002 | 826,145 | +32% | CVI Investments, Inc. | 30 Jun 2025 |
| Orca Capital AG | 4.9% | -13% | $515,257 | -$11,765 | 362,857 | -2.2% | Orca Capital AG | 07 May 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $451,365 | 317,863 | Mitchell P. Kopin | 06 May 2025 | |||
| ARMISTICE CAPITAL, LLC | 5% | -50% | $201,756 | +$11,779 | 142,082 | +6.2% | Armistice Capital, LLC | 31 Mar 2025 |
| STEINMAN LAWRENCE | 3.1% | $119,078 | 83,858 | Lawrence Steinman | 01 Mar 2025 |
As of 30 Sep 2025, 18 institutional investors reported holding 612,004 shares of Pasithea Therapeutics Corp. - Common Stock (KTTA). This represents 0.6% of the company’s total 102,398,919 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 612,004 | $441,403 | +$224,538 | $0.73 | 18 |
| 2025 Q2 | 300,344 | $216,624 | +$151,923 | $0.72 | 10 |
| 2025 Q1 | 78,704 | $99,102 | -$116,583 | $1.30 | 7 |
| 2024 Q4 | 77,162 | $243,273 | +$214,440 | $3.15 | 7 |
| 2024 Q3 | 9,086 | $48,891 | -$103,371 | $5.42 | 6 |
| 2024 Q2 | 29,996 | $151,569 | -$300 | $5.06 | 7 |
| 2024 Q1 | 30,055 | $218,102 | +$218,102 | $7.28 | 6 |